Endocrinology and Metabolism (Jun 2021)

Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma

  • Jiyeon Ahn,
  • Ji Yun Park,
  • Gyuri Kim,
  • Sang-Man Jin,
  • Kyu Yeon Hur,
  • Soo-Youn Lee,
  • Jae Hyeon Kim

DOI
https://doi.org/10.3803/EnM.2020.925
Journal volume & issue
Vol. 36, no. 3
pp. 697 – 701

Abstract

Read online

Background Pheochromocytoma and paraganglioma (PPGL) is diagnosed through biochemical confirmation of excessive catecholamines in urine and plasma. Recent technological developments have allowed us to measure urinary free metanephrines; however, the diagnostic accuracy of these new methods and the diagnostic cutoff values have not been evaluated. Methods This is a retrospective study of 595 subjects, including 71 PPGL cases and 524 controls. PPGL was based on pathological confirmation. Subjects with no evidence of PPGL over 2 years were included in the control group. Results Urinary free metanephrines yielded similar area under the curve (AUC) to urinary fractionated metanephrines and plasma free metanephrines. However, urinary free normetanephrine yielded a better AUC than did urinary fractionated normetanephrine. The optimal cutoff for urinary free metanephrine and normetanephrine corrected for urinary creatinine yielded 97.2% sensitivity and 98.1% specificity. Conclusion Urinary free metanephrines are a reliable method for diagnosing PPGL in Asian populations compared with existing biochemical methods.

Keywords